Replies to post #600490 on NorthWest Biotherapeutics Inc (NWBO)

[attilathehunt]

Maybe there are two separate submissions (simultaneously) so GBM is not held up due to further discussions regarding the agnostic submission.


If it is worth a shot, then to separate the two may be the best option.

[biosectinvestor]

I have no doubt that the DCVax platform will ultimately qualify as tissue agnostic. As a regulatory matter, I see no possibility that they are applying initially for anything vaguely like a tissue agnostic approval. I do think once approved for any indication, expansion of the indications is much, much easier and they may very well even use real world data for those applications.